Scynexis SCYX
NASDAQ SCYX
$4.91 -0.24 (-4.66%)
At close: Sep 9, 2026 · 4:00 PM EDT

Scynexis (SCYX) Revenue (2013 - 2026)

Scynexis' (SCYX) quarterly Revenue came in at $235000.0 in Q2 2026, down 82.77% on a YoY basis from $1.4 million in Q2 2025, and down 98.74% quarter-over-quarter from $18.6 million in Q4 2025.

Analysis

Scynexis (SCYX) Revenue (2013 - 2026) Analysis & Trends

Scynexis (SCYX) has reported Revenue for 13 consecutive years, with $235000.0 the latest figure, recorded in Q2 2026.

  • For the quarter ending Q2 2026, Revenue fell 82.77% year-over-year to $235000.0; the trailing twelve-month figure through Jun 2026 stood at $19.2 million (up 489.78% YoY), and the FY2025 full-year result was $20.6 million, up 449.95% from the prior year.
  • Revenue declined to $235000.0 in Q2 2026 per SCYX's latest filing, from $18.6 million in the prior quarter.
  • Across five years, Revenue topped out at $131.5 million in Q2 2023 and bottomed at $235000.0 in Q2 2026.
  • Historically, Revenue has averaged $10.0 million across 5 years, with a median of $1.3 million in 2022.
  • The sharpest annual moves came in 2023 and 2024: Revenue surged 9836.05% in 2023, then slumped 99.44% in 2024.
  • Over 5 years, Revenue stood at $1.5 million in 2022, then surged by 280.38% to $5.8 million in 2023, then tumbled by 83.15% to $977000.0 in 2024, then soared by 1808.5% to $18.6 million in 2025, then tumbled by 98.74% to $235000.0 in 2026.
  • According to Business Quant data, Revenue over the past three periods registered $235000.0, $18.6 million, and $334000.0 for Q2 2026, Q4 2025, and Q3 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Revenue (Qtr)
1 Amgen 236.37 Bn 222.38 Bn 7.24 Bn 10.05 Bn
2 Gilead Sciences 187.38 Bn 184.12 Bn 6.22 Bn 7.80 Bn
3 Vertex Pharmaceuticals 138.36 Bn 130.51 Bn 2.84 Bn 3.33 Bn
4 Regeneron Pharmaceuticals 85.09 Bn 77.10 Bn 3.93 Bn 4.29 Bn
5 Argenx Se 63.93 Bn 58.75 Bn 1.37 Bn 1.52 Bn
6 Moderna 58.07 Bn 52.94 Bn 52.00 Mn 145.00 Mn
7 Alnylam Pharmaceuticals 35.59 Bn 32.28 Bn 992.69 Mn 1.29 Bn
8 Biogen 32.63 Bn 31.34 Bn 1.96 Bn 2.74 Bn
9 Insmed 27.57 Bn 26.41 Bn 358.27 Mn 425.49 Mn
10 Scynexis 52.73 Mn -61.96 Mn - 235,000.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 235,000.00
Dec 31, 2025 18.65 Mn
Sep 30, 2025 334,000.00
Jun 30, 2025 1.36 Mn
Mar 31, 2025 257,000.00
Dec 31, 2024 977,000.00
Sep 30, 2024 660,000.00
Jun 30, 2024 736,000.00
Mar 31, 2024 1.37 Mn
Dec 31, 2023 5.80 Mn
Sep 30, 2023 1.76 Mn
Jun 30, 2023 131.45 Mn
Mar 31, 2023 1.13 Mn
Dec 31, 2022 1.52 Mn
Sep 30, 2022 1.56 Mn
Jun 30, 2022 1.32 Mn
Mar 31, 2022 700,000.00
Dec 31, 2021 597,000.00
Sep 30, 2021 516,000.00
Mar 31, 2021 12.05 Mn